1-3 of 3
Neslihan Kalkan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Should “Medically Fit” Older Patients with Acute Myeloid Leukemia (AML) Continue to Receive Intensive Chemotherapy in the Venetoclax (VEN) Era?

Free
Nilesh Kapoor, Ang Gao, Ruth Ikpefan, Chul Ahn, Julia Anderson, F Neslihan Kalkan, Weina Chen, Sharon Germans, Alejandro Marinos Velarde, Vivian Irrizary Gatell, Julio Alvarenga Thiebaud, Clayton Jackson, Olga K. Weinberg, Miguel Cantu, Robert H. Collins, Stephen Chung, Yazan F Madanat
Journal: Blood
Blood (2024) 144 (Supplement 1): 4234.
https://doi.org/10.1182/blood-2024-204314
Published: 2024
Journal Articles

Drug Combinations on AML Cell Lines' Treatment

Free
Fatma Neslihan Kalkan, Ezgi Temamogullari Wood, Micheal Farid, Muhammed Sadik Yildiz, Stephen S. Chung, Erdal Toprak
Journal: Blood
Blood (2022) 140 (Supplement 1): 12999–13000.
https://doi.org/10.1182/blood-2022-171100
Published: 2022
Journal Articles

Long-Term Outcome of Deferasirox Chelation in Patients with Thalassemia Major

Free
Sule Unal, Neslihan Kalkan, Mualla Cetin, Prof. Dr., Fatma Gumruk
Journal: Blood
Blood (2016) 128 (22): 3620.
https://doi.org/10.1182/blood.V128.22.3620.3620
Published: 2016